Related Experiment Videos

Noninvasive atherosclerosis assessment for controlled clinical trials

D H Blankenhorn

Advances in Experimental Medicine and Biology

|January 1, 1985

Summary

Detecting atherosclerosis progression in clinical trials is now possible with advanced imaging. Non-invasive techniques like IV angiography and ultrasound show promise for tracking yearly changes in atherosclerosis growth.

Failed At:

2026-06-19T13:49:29.287631+00:00

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study.

Circulation·1996

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).

Arteriosclerosis and thrombosis : a journal of vascular biology·1994

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.

Circulation·1994

George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal.

Arteriosclerosis and thrombosis : a journal of vascular biology·1994

One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy.

Stroke·1993

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

Annals of internal medicine·1993

See all related articles